Sysmex : OncoGuide™ NCC Oncopanel System Receives Insurance Coverage as a Companion Diagnostic for Futibatinib, a Treatment for Advanced Biliary Tract Cancer -Today at 02:04 am
Aug. 30, 2023 Sysmex Corporation announces that the OncoGuide™ NCC Oncopanel System is now covered by health insurance in Japan as a companion diagnostic for...
National Cancer Center Sysmex Group Cancer Statistics National Registry Cancer Information Service National Cancer Incidence Data Sysmex Corporation
Source: marketscreener.com